Overview

Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis

Status:
Not yet recruiting

Trial end date:
2023-08-21

Target enrollment:

Participant gender:

Summary

This study will compare the PK parameters of the combination test formulation to monotherapy reference products (mometasone furoate and azelastine hydrochloride) in adolescents and young adult patients with seasonal allergic rhinitis.

Phase:

Phase 1

Details

Lead Sponsor:

Sandoz

Treatments:

Azelastine
Mometasone Furoate